Advocated for medicare reimbursement for skin substitutes that are used to heal wounds caused from diabetes.
2026 · 2nd Quarter (Apr 1 - June 30)
BIOSTEM TECHNOLOGIES
Filed by BALLARD PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Termination
- Posted
- Jul 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- BALLARD PARTNERS
- Client
- BIOSTEM TECHNOLOGIES
- Filing UUID
- 138f142c-7303-43f0-a7ee-45b50537387e
- Termination date
- May 12, 2026
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.